|
AUTS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.52360379657557E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.51639964210915E-10 |
| Normal-vs-Stage2 |
6.88419999894663E-08 |
| Normal-vs-Stage3 |
1.45790046701677E-11 |
| Normal-vs-Stage4 |
1.3611001214997E-11 |
| Stage1-vs-Stage2 |
4.576200E-01 |
| Stage1-vs-Stage3 |
2.812100E-02 |
| Stage1-vs-Stage4 |
3.768800E-04 |
| Stage2-vs-Stage3 |
4.390600E-01 |
| Stage2-vs-Stage4 |
4.864300E-02 |
| Stage3-vs-Stage4 |
2.098600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34240396576502E-11 |
| Normal-vs-AfricanAmerican |
7.43250000434514E-08 |
| Normal-vs-Asian |
2.25139999999735E-05 |
| Caucasian-vs-AfricanAmerican |
9.281200E-01 |
| Caucasian-vs-Asian |
3.193000E-01 |
| AfricanAmerican-vs-Asian |
4.614200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.06920078030748E-11 |
| Normal-vs-Female |
2.84860024457601E-10 |
| Male-vs-Female |
6.734600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.82836999998992E-05 |
| Normal-vs-Extreme_Weight |
1.33819999525997E-09 |
| Normal-vs-Obese |
9.64049950979984E-10 |
| Normal-vs-Extreme_Obese |
3.17479999956127E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.740400E-01 |
| Normal_Weight-vs-Obese |
9.543600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.713400E-01 |
| Extreme_Weight-vs-Obese |
8.816600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.854400E-01 |
| Obese-vs-Extreme_Obese |
3.060800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.71530000203646E-08 |
| Normal-vs-Age(41-60Yrs) |
1.16870000343994E-08 |
| Normal-vs-Age(61-80Yrs) |
5.73485703370125E-12 |
| Normal-vs-Age(81-100Yrs) |
9.337300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.343210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.211200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.922400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.043800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.265600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.410200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.92689994463302E-09 |
| Normal-VS-Type2 PRCC |
2.1094237467878E-14 |
| Normal-VS-KIRP CIMP |
4.14790424230205E-11 |
| Normal-VS-Unclassified PRCC |
4.0206005191834E-10 |
| Type1 PRCC-VS-Type2 PRCC |
9.79389999999913E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.384300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.524000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.669200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.959400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.381400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.27360377589048E-11 |
| Normal-vs-N1 |
9.54791801177635E-15 |
| Normal-vs-N2 |
4.05460000000302E-05 |
| N0-vs-N1 |
1.171210E-01 |
| N0-vs-N2 |
4.027800E-01 |
| N1-vs-N2 |
5.319000E-01 |
|
|
